Cencora (NYSE:COR) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding ...

Cencora COR underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light on ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on COR stock, giving a Buy rating on January 14. Ann Hynes has given her Buy rating due to a combination of factors ...

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.

Cencora, Inc. (NYSE:COR), a $47.7 billion market cap leader in the wholesale drug distribution industry, disclosed today that two of its long-standing board members, Richard W. Gochnauer and ...

To make sure we’ve got our fingers on the pulse, we caught up with Bydee’s Founder, Dessy Hairis, to unpack the swimwear trends that we’re seeing across Australian beaches. According to ...

Animal rescuers have helped save pets affected by devastating wildfires in Southern California by flying more than 80 cats and dogs to a no-kill shelter in Utah. The flight carried 26 dogs and 58 ...

Cencora, Inc. (NYSE:COR – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eleven ratings firms that are presently covering the stock, MarketBeat reports.

Cencora, Inc. has a fifty-two week low of $214.77 and a fifty-two week high of $253.27. Cencora Increases Dividend The business also recently announced a quarterly dividend, which was paid on ...

Costco, Cencora, West Pharmaceutical Services, Danaher, Madison Square Garden Sports, and Estée Lauder appear to be at risk of disappointing investors in 2025. Weakening technical performance vs.